Filing Details

Accession Number:
0001415889-24-015587
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-05 16:57:42
Reporting Period:
2024-06-03
Accepted Time:
2024-06-05 16:57:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649094 Vaxcyte Inc. PCVX Biological Products, (No Disgnostic Substances) (2836) 464233385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1813798 Jim Wassil C/O Vaxcyte, Inc.
825 Industrial Road, Ste. 300
San Carlos CA 94070
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-03 1,634 $71.38 214,869 No 4 S Direct
Common Stock Disposition 2024-06-03 906 $72.32 213,964 No 4 S Direct
Common Stock Disposition 2024-06-03 460 $73.48 213,503 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2023.
  2. The price reported is a weighted-average price. The shares were sold at prices ranging from $70.98 to $71.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Includes 1,041 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2024.
  4. The price reported is a weighted-average price. The shares were sold at prices ranging from $72.01 to $72.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. The price reported is a weighted-average price. The shares were sold at prices ranging from $73.41 to $73.54. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.